These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 24806321)
1. Tissue factor and tissue factor pathway inhibitor in women with a past history of preeclampsia: implication for a hypercoagulable state postpregnancy. Lwaleed BA; Breish MO; Birch BR; Chowdhary AP; Saad RA; Perigo O; Kazmi RS; Dusse LM; Cooper AJ Blood Coagul Fibrinolysis; 2014 Oct; 25(7):671-4. PubMed ID: 24806321 [TBL] [Abstract][Full Text] [Related]
2. Preeclampsia: the role of tissue factor and tissue factor pathway inhibitor. Godoi LC; Gomes KB; Alpoim PN; Carvalho Md; Lwaleed BA; Sant'Ana Dusse LM J Thromb Thrombolysis; 2012 Jul; 34(1):1-6. PubMed ID: 22461171 [TBL] [Abstract][Full Text] [Related]
3. The relationship between plasma and placental tissue factor, and tissue factor pathway inhibitors in severe pre-eclampsia patients. Teng Y; Jiang R; Lin Q; Ding C; Ye Z Thromb Res; 2010 Jul; 126(1):e41-5. PubMed ID: 20226500 [TBL] [Abstract][Full Text] [Related]
4. Tissue factor-dependent pathway in severe preeclampsia revisited: a Brazilian cohort study. Dusse LM; Godoi LC; Gomes KB; Carvalho Md; Lwaleed BA Blood Coagul Fibrinolysis; 2016 Jun; 27(4):436-40. PubMed ID: 26765308 [TBL] [Abstract][Full Text] [Related]
5. Tissue factor dependent pathway and the diagnosis of pre-eclampsia. Lwaleed BA; Dusse L; Cooper AJ Semin Thromb Hemost; 2011 Mar; 37(2):125-30. PubMed ID: 21370212 [TBL] [Abstract][Full Text] [Related]
6. Alternations of maternal and cord plasma hemostasis in preeclampsia before and after delivery. Xiong Y; Zhou SF; Zhou R; Yang D; Xu ZF; Lou YT; Guo QS; Hu R; Peng T; Ma D; Li XT Hypertens Pregnancy; 2011; 30(3):347-58. PubMed ID: 21174589 [TBL] [Abstract][Full Text] [Related]
7. Microparticles (MPs), tissue factor (TF) and tissue factor inhibitor (TFPI) in cord blood plasma. A preliminary study and literature survey of procoagulant properties of MPs. Uszyński M; Zekanowska E; Uszyński W; Kuczyński J; Zyliński A Eur J Obstet Gynecol Reprod Biol; 2011 Sep; 158(1):37-41. PubMed ID: 21664032 [TBL] [Abstract][Full Text] [Related]
8. Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation. Shimura M; Wada H; Wakita Y; Nakase T; Hiyoyama K; Nagaya S; Mori Y; Shiku H Am J Hematol; 1996 Jul; 52(3):165-70. PubMed ID: 8756081 [TBL] [Abstract][Full Text] [Related]
10. Tissue factor activity in women with preeclampsia or SGA: a potential explanation for the excessive thrombin generation in these syndromes. Erez O; Romero R; Vaisbuch E; Than NG; Kusanovic JP; Mazaki-Tovi S; Gotsch F; Mittal P; Dong Z; Chaiworapongsa T; Kim CJ; Nhan-Chang CL; Kim SK; Yeo L; Mazor M; Hassan SS J Matern Fetal Neonatal Med; 2018 Jun; 31(12):1568-1577. PubMed ID: 28521572 [TBL] [Abstract][Full Text] [Related]
11. [Change of tissue factor pathway ratio during attack in patients with acute myocardial infarction and its clinical significance]. Wang R; Wen BZ; Ma YT; Peng -; Li H; Zhong D; Li L Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):198-202. PubMed ID: 19236778 [TBL] [Abstract][Full Text] [Related]
12. Tissue factor, tissue pathway factor inhibitor and risk factors of atherosclerosis in patients with chronic limbs ischemia: preliminary study. Gosk-Bierska I; Wysokin Ski W; Karnicki K; Adamiec R Int Angiol; 2008 Aug; 27(4):296-301. PubMed ID: 18677291 [TBL] [Abstract][Full Text] [Related]
13. The role of tissue factor in normal pregnancy and in the development of preeclampsia: A review. Prochazkova J; Slavik L; Ulehlova J; Prochazka M Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):192-6. PubMed ID: 25559093 [TBL] [Abstract][Full Text] [Related]
14. Plasma tissue factor and tissue factor pathway inhibitor in patients with primary glomerulonephritis. Lizakowski S; Zdrojewski Z; Jagodzinski P; Rutkowski B Scand J Urol Nephrol; 2007; 41(3):237-42. PubMed ID: 17469034 [TBL] [Abstract][Full Text] [Related]
15. Tissue factor and its inhibitor in human non-crescentic glomerulonephritis--immunostaining vs plasma and urinary levels. Naumnik B; Borawski J; Chyczewski L; Pawlak K; Mysliwiec M Nephrol Dial Transplant; 2006 Dec; 21(12):3450-7. PubMed ID: 16982632 [TBL] [Abstract][Full Text] [Related]
16. Impaired control of the tissue factor pathway of blood coagulation in systemic lupus erythematosus. Adams MJ; Palatinus AA; Harvey AM; Khalafallah AA Lupus; 2011 Dec; 20(14):1474-83. PubMed ID: 21993387 [TBL] [Abstract][Full Text] [Related]
17. The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome. Amengual O; Atsumi T; Khamashta MA; Hughes GR Thromb Haemost; 1998 Feb; 79(2):276-81. PubMed ID: 9493575 [TBL] [Abstract][Full Text] [Related]
18. Tissue factor and its natural inhibitor in pre-eclampsia and SGA. Erez O; Romero R; Hoppensteadt D; Than NG; Fareed J; Mazaki-Tovi S; Espinoza J; Chaiworapongsa T; Kim SS; Yoon BH; Hassan SS; Gotsch F; Friel L; Vaisbuch E; Kusanovic JP J Matern Fetal Neonatal Med; 2008 Dec; 21(12):855-69. PubMed ID: 19065458 [TBL] [Abstract][Full Text] [Related]
19. Increased risk of gestational vascular complications in women with low free tissue factor pathway inhibitor plasma levels out of pregnancy. Ittel A; Bretelle F; Gris JC; Chau C; Sébahoun G; Boubli L; Arnoux D Thromb Haemost; 2011 Jan; 105(1):66-71. PubMed ID: 20978710 [TBL] [Abstract][Full Text] [Related]
20. Plasma factor VII: a potential marker of pre-eclampsia. Dusse LM; Carvalho MG; Cooper AJ; Lwaleed BA Thromb Res; 2011 Jan; 127(1):e15-9. PubMed ID: 21094984 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]